Remus Pharmaceuticals Limited (NSE:REMUS)
650.00
+12.75 (2.00%)
Apr 16, 2026, 2:39 PM IST
-36.38% (1Y)
| Market Cap | 7.43B -37.0% |
| Revenue (ttm) | 7.48B +63.8% |
| Net Income | 335.10M +12.1% |
| EPS | 27.37 +7.9% |
| Shares Out | 11.66M |
| PE Ratio | 23.29 |
| Forward PE | n/a |
| Dividend | 1.00 (0.16%) |
| Ex-Dividend Date | Nov 14, 2025 |
| Volume | 1,300 |
| Average Volume | 4,295 |
| Open | 641.00 |
| Previous Close | 637.25 |
| Day's Range | 639.30 - 651.00 |
| 52-Week Range | 580.00 - 1,139.50 |
| Beta | 0.22 |
| RSI | 48.90 |
| Earnings Date | May 15, 2026 |